Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.72)
# 3,413
Out of 5,102 analysts
207
Total ratings
22.75%
Success rate
-6.87%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.08 | +733.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.40 | +1,921.22% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.80 | +227.59% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.17 | +241.88% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $3.26 | -38.65% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $4.83 | +4,040.79% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.21 | +759.73% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.76 | +1,093.18% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.27 | +1,081.10% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $3.72 | +14,953.76% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $10.33 | +1,061.67% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.03 | +468.99% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.90 | +1,478.95% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.74 | +181.90% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.70 | +841.18% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.99 | +506.06% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.17 | +8,447.01% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.31 | +5,706.45% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.28 | +777.19% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.86 | +268,671.33% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $16.98 | +2,844.64% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $34.41 | +597.47% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.35 | +5,825.93% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $5.92 | +25,237.84% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $9.82 | +81,366.40% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.28 | +446.88% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.89 | +1,487.30% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.61 | +767.68% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $6.53 | +175.65% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.49 | -8.93% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $10.93 | +13,074.75% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $60.32 | -60.21% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.06 | +322,541.51% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.22 | +1,557,277.05% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.40
Upside: +1,921.22%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.80
Upside: +227.59%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.17
Upside: +241.88%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.26
Upside: -38.65%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $4.83
Upside: +4,040.79%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.21
Upside: +759.73%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.76
Upside: +1,093.18%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.27
Upside: +1,081.10%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $3.72
Upside: +14,953.76%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $10.33
Upside: +1,061.67%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $7.03
Upside: +468.99%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.90
Upside: +1,478.95%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.74
Upside: +181.90%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $1.70
Upside: +841.18%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.99
Upside: +506.06%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.17
Upside: +8,447.01%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.31
Upside: +5,706.45%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.28
Upside: +777.19%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.86
Upside: +268,671.33%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $16.98
Upside: +2,844.64%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $34.41
Upside: +597.47%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.35
Upside: +5,825.93%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $5.92
Upside: +25,237.84%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $9.82
Upside: +81,366.40%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.28
Upside: +446.88%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.89
Upside: +1,487.30%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.61
Upside: +767.68%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $6.53
Upside: +175.65%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $5.49
Upside: -8.93%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $10.93
Upside: +13,074.75%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $60.32
Upside: -60.21%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.06
Upside: +322,541.51%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.22
Upside: +1,557,277.05%